Skip to content

Drug interactions

Lonafarnib + Sofosbuvir-velpatasvir

Severity: Moderate

Lonafarnib and Sofosbuvir-velpatasvir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lonafarnib is a strong CYP3A inhibitor and may raise velpatasvir exposure, though velpatasvir has a wide safety margin. Lonafarnib levels are not expected to be substantially affected by the antivirals.

What this interaction means in plain words

Lonafarnib and Sofosbuvir-velpatasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lonafarnib belongs to Miscellaneous; Sofosbuvir-velpatasvir belongs to Anti Virals.

Evidence level: Low

Why it happens

Lonafarnib inhibits CYP3A4, reducing velpatasvir metabolism.

What to do

Monitor for velpatasvir adverse effects such as headache and fatigue. No dose change is established for the antiviral combination.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lonafarnib and Sofosbuvir-velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lonafarnib with Sofosbuvir-velpatasvir?

MediHelp rates the interaction as moderate. Lonafarnib and Sofosbuvir-velpatasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lonafarnib is a strong CYP3A inhibitor and may raise velpatasvir exposure, though velpatasvir has a wide safety margin. Lonafarnib levels are not expected to be substantially affected by the antivirals.

How serious is the interaction between Lonafarnib and Sofosbuvir-velpatasvir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for velpatasvir adverse effects such as headache and fatigue. No dose change is established for the antiviral combination.

What other medicines interact with Sofosbuvir-velpatasvir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir with, for example, Rifampin, Rifapentine, St john's wort. The full list is on the Sofosbuvir-velpatasvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in